Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.9157
+0.0508 (5.87%)
At close: Jun 18, 2026, 4:00 PM EDT
0.9100
-0.0057 (-0.62%)
After-hours: Jun 18, 2026, 5:51 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $85.2 million as of June 18, 2026. Its market cap has increased by 92.28% in one year.
Market Cap
85.20M
Enterprise Value
85.67M
1-Year Change
92.28%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $85.20M, a decrease of -46.37%. That is a compound annual growth rate of -6.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 85.20M | 179.40% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 88.41M |
| OS Therapies | 85.96M |
| ImmuCell | 85.85M |
| Aardvark Therapeutics | 85.74M |
| Biomea Fusion | 85.31M |
| MAIA Biotechnology | 85.12M |
| Adicet Bio | 85.06M |
| Rallybio | 84.48M |